At 12 weeks, a PGA score ≤ 1 was achieved in 32.8% of patients using home-based phototherapy and in 25.6% of those who received office-based phototherapy (P < .001).

Key takeaways: Body surface area and PGA scores were each reduced in patients treated with tildrakizumab. PASI 75, 90 and 100 were achieved by 87%, 56.5% and 32.6% of treated patients.

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...